PubRank

Paul D Bieniasz

Author PubWeight™ 180.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008 14.99
2 Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007 9.52
3 Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat Med 2003 5.97
4 Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc Natl Acad Sci U S A 2004 5.15
5 Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 2009 5.06
6 Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol 2008 4.72
7 Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc Natl Acad Sci U S A 2002 4.66
8 Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol 2006 4.43
9 Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc Natl Acad Sci U S A 2003 4.21
10 Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J 2003 4.19
11 Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog 2009 4.18
12 An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2007 4.17
13 Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 2009 4.11
14 HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane. PLoS Pathog 2006 3.97
15 Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification. PLoS Pathog 2005 3.59
16 Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity. J Virol 2005 3.54
17 Role of ESCRT-I in retroviral budding. J Virol 2003 3.36
18 APOBEC3G incorporation into human immunodeficiency virus type 1 particles. J Virol 2004 3.17
19 Imaging the biogenesis of individual HIV-1 virions in live cells. Nature 2008 2.92
20 HIV Restriction Factors and Mechanisms of Evasion. Cold Spring Harb Perspect Med 2012 2.72
21 Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells. J Virol 2005 2.54
22 Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog 2007 2.52
23 Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity. J Virol 2005 2.47
24 MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 2013 2.40
25 Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J Virol 2004 2.37
26 HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. J Cell Biol 2004 2.34
27 Adaptation to the interferon-induced antiviral state by human and simian immunodeficiency viruses. J Virol 2013 2.28
28 Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc Natl Acad Sci U S A 2008 2.23
29 Dynamics of ESCRT protein recruitment during retroviral assembly. Nat Cell Biol 2011 2.23
30 Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection. J Virol 2002 2.11
31 Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particles. Proc Natl Acad Sci U S A 2009 2.08
32 Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on gag precursor-membrane interactions. J Virol 2004 1.94
33 Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates. Virology 2006 1.94
34 Antiretroviral potential of human tripartite motif-5 and related proteins. Virology 2006 1.94
35 Context-dependent effects of L domains and ubiquitination on viral budding. J Virol 2004 1.92
36 Generation of simian-tropic HIV-1 by restriction factor evasion. Science 2006 1.84
37 A macaque model of HIV-1 infection. Proc Natl Acad Sci U S A 2009 1.76
38 Analysis of the initiating events in HIV-1 particle assembly and genome packaging. PLoS Pathog 2010 1.66
39 Integration target site selection by a resurrected human endogenous retrovirus. Genes Dev 2009 1.62
40 Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells. J Virol 2004 1.57
41 Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo. Proc Natl Acad Sci U S A 2011 1.56
42 Ubiquitin-dependent virus particle budding without viral protein ubiquitination. Proc Natl Acad Sci U S A 2007 1.51
43 Hypermutation of an ancient human retrovirus by APOBEC3G. J Virol 2008 1.50
44 Structural insight into the mechanisms of enveloped virus tethering by tetherin. Proc Natl Acad Sci U S A 2010 1.39
45 SAMHD1-dependent retroviral control and escape in mice. EMBO J 2013 1.36
46 Extreme genetic fragility of the HIV-1 capsid. PLoS Pathog 2013 1.35
47 HIV/AIDS: in search of an animal model. Trends Biotechnol 2007 1.31
48 A role for ubiquitin ligases and Spartin/SPG20 in lipid droplet turnover. J Cell Biol 2009 1.30
49 Identification of human VPS37C, a component of endosomal sorting complex required for transport-I important for viral budding. J Biol Chem 2004 1.28
50 A bipartite late-budding domain in human immunodeficiency virus type 1. J Virol 2003 1.25
51 Mechanism of HIV-1 virion entrapment by tetherin. PLoS Pathog 2013 1.24
52 Vpu binds directly to tetherin and displaces it from nascent virions. PLoS Pathog 2013 1.21
53 SIV Nef proteins recruit the AP-2 complex to antagonize Tetherin and facilitate virion release. PLoS Pathog 2011 1.20
54 The betaretrovirus Mason-Pfizer monkey virus selectively excludes simian APOBEC3G from virion particles. J Virol 2006 1.17
55 Primate lentivirus capsid sensitivity to TRIM5 proteins. J Virol 2008 1.16
56 Fates of retroviral core components during unrestricted and TRIM5-restricted infection. PLoS Pathog 2013 1.13
57 Functional interchangeability of late domains, late domain cofactors and ubiquitin in viral budding. PLoS Pathog 2010 1.10
58 Inhibition of HIV-1 particle assembly by 2',3'-cyclic-nucleotide 3'-phosphodiesterase. Cell Host Microbe 2012 1.09
59 Identification of domains in gag important for prototypic foamy virus egress. J Virol 2005 1.09
60 Human APOBEC3 proteins can inhibit xenotropic murine leukemia virus-related virus infectivity. Virology 2010 1.09
61 No effect of endogenous TRIM5alpha on HIV-1 production. Nat Med 2008 1.08
62 Visualizing HIV-1 assembly. J Mol Biol 2011 1.07
63 Matrix-induced inhibition of membrane binding contributes to human immunodeficiency virus type 1 particle assembly defects in murine cells. J Virol 2005 1.05
64 Clathrin facilitates the morphogenesis of retrovirus particles. PLoS Pathog 2011 1.05
65 Effect of DNA repair protein Rad18 on viral infection. PLoS Pathog 2006 0.99
66 Evidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5alpha proteins. PLoS Pathog 2008 0.99
67 HIV-1 at 25. Cell 2008 0.94
68 Antiretroviral restriction factors. Curr Opin Virol 2011 0.93
69 Assisted evolution enables HIV-1 to overcome a high TRIM5α-imposed genetic barrier to rhesus macaque tropism. PLoS Pathog 2013 0.90
70 Identification of a receptor for an extinct virus. Proc Natl Acad Sci U S A 2010 0.84
71 A facile quantitative assay for viral particle genesis reveals cooperativity in virion assembly and saturation of an antiviral protein. Virology 2012 0.81
72 Cyclin T1 expression is mediated by a complex and constitutively active promoter and does not limit human immunodeficiency virus type 1 Tat function in unstimulated primary lymphocytes. J Virol 2002 0.79
73 Sensing retroviruses. Immunity 2011 0.75
74 Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine Dose. bioRxiv 2022 0.75